dc.contributor.author
Huo, Shufan
dc.contributor.author
Ferse, Caroline
dc.contributor.author
Bösl, Fabian
dc.contributor.author
Reincke, S. Momsen
dc.contributor.author
Enghard, Philipp
dc.contributor.author
Hinrichs, Carl
dc.contributor.author
Treskatsch, Sascha
dc.contributor.author
Angermair, Stefan
dc.contributor.author
Eckardt, Kai-Uwe
dc.contributor.author
Audebert, Heinrich J.
dc.contributor.author
Ploner, Christoph J.
dc.contributor.author
Endres, Matthias
dc.contributor.author
Prüss, Harald
dc.contributor.author
Franke, Christiana
dc.contributor.author
Scheibe, Franziska
dc.date.accessioned
2024-10-01T09:48:23Z
dc.date.available
2024-10-01T09:48:23Z
dc.identifier.uri
https://refubium.fu-berlin.de/handle/fub188/45109
dc.identifier.uri
http://dx.doi.org/10.17169/refubium-44821
dc.rights.uri
https://creativecommons.org/licenses/by/4.0/
dc.subject
Brain Diseases
en
dc.subject
Immunoglobulins, Intravenous
en
dc.subject
COVID-19 complications
en
dc.subject.ddc
600 Technik, Medizin, angewandte Wissenschaften::610 Medizin und Gesundheit::610 Medizin und Gesundheit
dc.title
Intravenous immunoglobulins for treatment of severe COVID-19-related acute encephalopathy
dc.type
Wissenschaftlicher Artikel
dcterms.bibliographicCitation.doi
10.1007/s00415-022-11152-5
dcterms.bibliographicCitation.journaltitle
Journal of Neurology
dcterms.bibliographicCitation.number
8
dcterms.bibliographicCitation.originalpublishername
Springer Nature
dcterms.bibliographicCitation.pagestart
4013
dcterms.bibliographicCitation.pageend
4020
dcterms.bibliographicCitation.volume
269
refubium.affiliation
Charité - Universitätsmedizin Berlin
refubium.funding
Springer Nature DEAL
refubium.resourceType.isindependentpub
no
dcterms.accessRights.openaire
open access
dcterms.bibliographicCitation.pmid
35538168
dcterms.isPartOf.issn
0340-5354
dcterms.isPartOf.eissn
1432-1459